These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 6643342)

  • 1. Potentiation of phagocytosis of Bacteroides fragilis following incubation with clindamycin.
    Howard RJ; Soucy DM
    J Antimicrob Chemother; 1983 Oct; 12 Suppl C():63-8. PubMed ID: 6643342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions of Bacteroides fragilis and phagocytes: studies with whole organisms, purified capsular polysaccharide and clindamycin-treated bacteria.
    Wade BH; Kasper DL; Mandell GL
    J Antimicrob Chemother; 1983 Oct; 12 Suppl C():51-62. PubMed ID: 6643341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibiotic-induced modification of Bacteroides fragilis and its susceptibility to phagocytosis by human polymorphonuclear leukocytes.
    Gemmell CG; Peterson PK; Schmeling D; Mathews J; Quie PG
    Eur J Clin Microbiol; 1983 Aug; 2(4):327-34. PubMed ID: 6628373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Bacteroides fragilis grown in the presence of clindamycin, metronidazole and fusidic acid on opsonization and killing of Escherichia coli.
    Namavar F; Kaan JA; Verweij-van Vught AM; Vel WA; Bal M; Kester AD; MacLaren DM
    Eur J Clin Microbiol; 1986 Jun; 5(3):324-9. PubMed ID: 3527702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of glycocalyx in surface phagocytosis of Bacteroides spp., in the presence and absence of clindamycin.
    Veringa EM; Ferguson DA; Lambe DW; Verhoef J
    J Antimicrob Chemother; 1989 May; 23(5):711-20. PubMed ID: 2474527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of opsonophagocytosis of Bacteroides spp. by clindamycin in subinhibitory concentrations.
    Veringa EM; Lambe DW; Ferguson DA; Verhoef J
    J Antimicrob Chemother; 1989 Apr; 23(4):577-87. PubMed ID: 2745261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology of clindamycin resistance in the Bacteroides fragilis group.
    Reig M; Campello MG; Baquero F
    J Antimicrob Chemother; 1984 Dec; 14(6):595-603. PubMed ID: 6520060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clindamycin and its action on the susceptibility of pathogenic bacteria to phagocytosis.
    Gemmell CG
    Scand J Infect Dis Suppl; 1984; 43():17-23. PubMed ID: 6398907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased resistance of encapsulated Bacteroides fragilis to clindamycin.
    Brook I; Gillmore JD
    Chemotherapy; 1994; 40(1):16-20. PubMed ID: 8306810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Susceptibility of anaerobic bacteria to five antimicrobial agents and demonstration of resistance of Bacteroides fragilis to clindamycin.
    Sofianou D; Douboyas J; Papapanagiotou J; Paradelis AG
    Methods Find Exp Clin Pharmacol; 1982; 4(3):173-7. PubMed ID: 7121128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations in opsonophagocytic killing by neutrophils of Bacteroides fragilis associated with animal and laboratory passage: effect of capsular polysaccharide.
    Simon GL; Klempner MS; Kasper DL; Gorbach SL
    J Infect Dis; 1982 Jan; 145(1):72-7. PubMed ID: 7054319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relative antibacterial efficacy of clindamycin and metronidazole against Bacteroides fragilis in vitro and in experimentally infected mice.
    Dijkmans BA; Vaishnav J; Mattie H
    Chemotherapy; 1985; 31(4):297-303. PubMed ID: 4028873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of metronidazole, chloramphenicol, clindamycin and penicillin G on growth and neuraminidase activity of Bacteroides fragilis.
    Ferreira MC; Domingues RM; de Uzeda M
    J Antimicrob Chemother; 1989 Aug; 24(2):157-64. PubMed ID: 2793640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of phagocytosis of E. coli by B. fragilis group--an in vitro study.
    Beena VK; Kumari N; Shivananda PG
    Indian J Pathol Microbiol; 1997 Jul; 40(3):373-6. PubMed ID: 9354011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasmid-mediated, transferable resistance to clindamycin and erythromycin in Bacteroides fragilis.
    Tally FP; Snydman DR; Gorbach SL; Malamy MH
    J Infect Dis; 1979 Jan; 139(1):83-8. PubMed ID: 438530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clindamycin resistance in anaerobic bacteria.
    Tally FP; Cuchural GJ; Bieluch VM; Jacobus NV; Malamy MH
    Scand J Infect Dis Suppl; 1984; 43():34-43. PubMed ID: 6598519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bactericidal activity of ceftizoxime, cefotetan, and clindamycin against cefoxitin-resistant strains of the Bacteroides fragilis group.
    Aldridge KE; Stratton CW
    J Antimicrob Chemother; 1991 Nov; 28(5):701-5. PubMed ID: 1778873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potentiation of phagocytosis of pathogenic bacteria by exposure to low concentrations of antibiotics.
    Gemmell CG
    J Antimicrob Chemother; 1984 May; 13(5):407-9. PubMed ID: 6735958
    [No Abstract]   [Full Text] [Related]  

  • 19. Transfer of multiple antibiotic resistance between subspecies of Bacteroides fragilis.
    Privitera G; Dublanchet A; Sebald M
    J Infect Dis; 1979 Jan; 139(1):97-101. PubMed ID: 108340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinical significance of clindamycin-resistant Bacteroides fragilis.
    Yee MH; Guiney DG; Hasegawa P; Davis CE
    JAMA; 1982 Oct; 248(15):1860-1. PubMed ID: 7120605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.